Asahi Kasei broadened its infectious disease franchise via Aicuris, adding commercial and clinical-stage antivirals aimed at ...
Aicuris’s three antiviral assets complement Asahi Kasei’s therapy portfolioAicuris revenue expected to reach $500 million by ...
IN BRIEF FASB's recent guidance on accounting joint ventures, ASU 2023-5, is intended to resolve diversity in practice and ...
Perma-Pipe International Holdings, Inc. (NASDAQ: PPIH) today announced financial results for the fourth quarter and 2025 fiscal year ended January 31, 2026. “For the three months ended January 31, ...
Opinion: Practitioners who treat the 2025 federal tax law simply as a gift-wrapped expansion of qualified small business ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results